Skip to main content Skip to section navigation Skip to footer
Axogen Corporate Home
    • About Us
    • Management Team
    • Board of Directors
    • Careers
    • Organizations We Work With
    • Grants, Donations and Sponsorships
    • Ethics and Compliance
    • Patents
  • For healthcare professionals
  • For patients
  • For investors
Skip to main content Skip to section navigation Skip to footer
Axogen, Inc. IR Overview
  • Overview
  • News/Events
    • News / Events Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Information
    • Financial Information Overview
    • Financial Results
    • Balance Sheet
    • Income Statement
    • Cash Flow
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Information
    • Contacts
    • FAQ

Axogen In the News

Investors

  • Overview
  • News/Events
    • News / Events Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Information
    • Financial Information Overview
    • Financial Results
    • Balance Sheet
    • Income Statement
    • Cash Flow
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Information
    • Contacts
    • FAQ
  • News/Events

  • News / Events Overview
  • Press Releases
  • Axogen In the News
  • IR Calendar
  • Clinical Conferences
  • Presentations
  • Email Alerts
Feb 3, 2023
Autograft, allograft use for nerve gap repair may have comparable recovery rates
Oct 17, 2022
From Start-up to NASDAQ – with Karen Zaderej
May 13, 2022
AxoGen CEO On Positive Topline Results For Avance Nerve Graft Product
May 13, 2022
Axogen announces positive topline data from Phase 3 nerve graft study
May 9, 2022
Kim Hamden shares the impact of tissue and organ donation
Apr 29, 2022
VOICES: Honoring the gift of life during Donate Life Month
Apr 15, 2022
Miss Gainesville sharing the importance of Donate Life Month
Apr 14, 2022
Miss Gainesville shares inspirational organ donation story in light of Donate Life Month
Mar 22, 2022
Advancements in human tissue and nerve repair, helping Axogen grow in Vandalia
Mar 22, 2022
Vandalia site will anchor company’s growth as new ‘Avance’ nerve graft is pursued
rss_feed RSS
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Next Pagearrow_forward
  • emailEmail Alerts
  • contact_pageContacts
  • rss_feedRSS News Feed
  • accessibilityAccessibility Statement
Axogen Corporate Home

13631 Progress Blvd, Suite 400
Alachua, FL 32615

Audience
  • For Healthcare Professionals
  • For Patients
  • For Investors
Resources
  • Privacy Policy
  • Terms and Conditions
  • Website Terms of Use
  • Medical Information
Corporate
  • About Axogen
  • Careers
  • Contact
  • News
YouTube company logo LinkedIn company logo Instagram company logo Facebook company logo X company logo

© 2026 Axogen Corporation. All Rights Reserved. All trademarks are the property of their respective owners. See Trademark & Copyright Notice for details.